Stock Research for MYGN

MYGN
Current Price

$33.1100


Latest Update: 2018-02-23 16:00:00

High
$ 33.1400
Low
$ 33.0800
Close
$ 33.1400
Volume
76990
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

MYGN Stock Chart & Research Data

The MYGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MYGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


MYGN Due diligence Resources & Stock Charts

The MYGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MYGN Detailed Price Forecast - CNN Money CNN View MYGN Detailed Summary - Google Finance
Yahoo View MYGN Detailed Summary - Yahoo! Finance Zacks View MYGN Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View MYGN Trends & Analysis - Trade-Ideas Barrons View MYGN Major Holders - Barrons
NASDAQ View MYGN Call Transcripts - NASDAQ Seeking View MYGN Breaking News & Analysis - Seeking Alpha
Spotlight View MYGN Annual Report - CompanySpotlight.com OTC Report View MYGN OTC Short Report - OTCShortReport.com
TradeKing View MYGN Fundamentals - TradeKing Charts View MYGN SEC Filings - Bar Chart
WSJ View Historical Prices for MYGN - The WSJ Morningstar View Performance/Total Return for MYGN - Morningstar
MarketWatch View the Analyst Estimates for MYGN - MarketWatch CNBC View the Earnings History for MYGN - CNBC
StockMarketWatch View the MYGN Earnings - StockMarketWatch MacroAxis View MYGN Buy or Sell Recommendations - MacroAxis
Bullish View the MYGN Bullish Patterns - American Bulls Short Pains View MYGN Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View MYGN Stock Mentions - StockTwits PennyStocks View MYGN Stock Mentions - PennyStockTweets
Twitter View MYGN Stock Mentions - Twitter Invest Hub View MYGN Investment Forum News - Investor Hub
Yahoo View MYGN Stock Mentions - Yahoo! Message Board Seeking Alpha View MYGN Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for MYGN - SECform4.com Insider Cow View Insider Transactions for MYGN - Insider Cow
CNBC View MYGN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MYGN - OTC Markets
Yahoo View Insider Transactions for MYGN - Yahoo! Finance NASDAQ View Institutional Holdings for MYGN - NASDAQ


Stock Charts

FinViz View MYGN Stock Insight & Charts - FinViz.com StockCharts View MYGN Investment Charts - StockCharts.com
BarChart View MYGN Stock Overview & Charts - BarChart Trading View View MYGN User Generated Charts - Trading View


Latest Financial News for MYGN

See what the IHS Markit Score report has to say about Myriad Genetics Inc.
Posted on Friday February 23, 2018

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.


NCCN Guidelines Broadly Endorse Biomarker Testing in Prostate Cancer
Posted on Tuesday February 20, 2018

SALT LAKE CITY, Feb. 20, 2018-- Myriad Genetics, Inc. today announced that the National Comprehensive Cancer Network has updated its medical guidelines for prostate cancer treatment to broadly include ...


Myriad Genetics Banks on Product Launches, Competition Rife
Posted on Monday February 19, 2018

Myriad Genetics (MYGN) focuses on strengthening the Molecular Diagnostics portfolio through product launches.


New Research Coverage Highlights LKQ, Myriad Genetics, Pilgrim's Pride, AutoNation, Regency Centers, and Amphenol — Consolidated Revenues, Company Growth, and Expectations for 2018
Posted on Friday February 16, 2018

NEW YORK, Feb. 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of LKQ ...


Myriad Genetics: Analyzing The Qualms Over The Multiple
Seeking Alpha - Feb 9, 2018
In late January, it was suggested the market's multiple for Myriad Genetics (at 30) was too high. Most investors would agree market multiples should be justifiable.
As Myriad Genetics INC (MYGN) Market Valuation Rose, Shareholder Cwm LLC Has ... - BZ Weekly
Dissecting the Insider Trading Patterns of Myriad Genetics, Inc. (MYGN) - StockNewsGazette

Myriad Genetics Reaches Analyst Target Price
Nasdaq - Feb 22, 2018
In recent trading, shares of Myriad Genetics, Inc. (Symbol: MYGN) have crossed above the average analyst 12-month target price of $32.92, changing hands for $33.31/share.

Myriad Genetics Banks on Product Launches, Competition Rife
Nasdaq - Feb 19, 2018
On Feb 16, we issued an updated research report on Myriad Genetics, Inc . MYGN . The stock carries a Zacks Rank #3 (Hold).
Myriad Genetics, Inc. (MYGN) Expected to Announce Quarterly Sales of $187.91 ... - StockNewsTimes
Analysts are on the Bearish side about Myriad Genetics, Inc. (NASDAQ:MYGN ... - Reurope

Myriad Genetics Inc. Q2 Income Advances
Nasdaq - Feb 6, 2018
(RTTNews.com) - Myriad Genetics Inc. ( MYGN ) released earnings for its second quarter that gained ground from last year. The company said its bottom line came in at $22.3 million, or $0.31 per share.

Enter a stock symbol to view the stock details.